XSAU
4007
Market cap1.31bUSD
Nov 12, Last price
30.82SAR
Name
Al Hammadi Holding Co
Chart & performance
P/E
20.39
P/S
3.99
EPS
1.51
Div yield, %
4.54%
Shrs. gr., 5y
0.02%
Rev. gr., 5y
4.48%
Revenues
1.23b
+6.99%
Net income
242m
-28.61%
CFO
216m
-53.55%
Dividend
Aug 16, 20260.27 SAR/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Established in Riyadh, Saudi Arabia, in 1985, Al Hammadi Holding Company specializes in the healthcare industry. Its core operations include the development, upkeep, and management of hospitals and medical centers across the Kingdom, primarily through its Medical Services and Pharmaceuticals Products divisions. Beyond direct healthcare provision, the company diversifies its business into the wholesale and retail distribution of medical equipment, pharmaceuticals, cosmetic products, and food and beverages. Al Hammadi also holds interests in real estate, acquiring and leasing land for construction, invests in various industrial ventures, and is involved in establishing and managing commercial centers. The company currently operates three healthcare facilities under the Al Hammadi Hospital brand, located in the Olaya, Suwaidi, and Al Nuzha districts of Riyadh.
Key people
Abdulaziz bin Mohammed Bin Hamad Al Hammadi
Non-Executive Chairman of the Board · since 2023
Mohammed Saeed Al Saafeen
Chief Financial Officer · since 2022
Mohammed Bin Saleh bin Mohammed Al Hammadi
Chief Executive Officer, Executive Vice Chairman of the Board, Managing Director · since 2023
Abdulaziz Saleh Mohammed Al Hammadi
Chief Operating Officer, Executive Director · since 2022
Reema Al Hammadi
Chief Medical Officer · since 2022
Safug Al Koraisi
Head - Intensive Care Units · since 2022
Daifallah Al Nakhli
Medical Director of Al Suwaidi Hospital, Head of Infection Control · since 2023
Abdullah Al Sueibi
Interim Medical Director of Al Hammadis Nuzha Hospital · since 2023
Human Resources Manager · since 2022
Wahid Raafat
Chief Internal Audit Executive · since 2023
Saad Abdul Muhssin bin Abdul Aziz Alhamidi
Independent Director · since 2022
Aziz Bin Mohammed Al Gaht
Independent Director · since 2018
Ahmed Bin Ibraheem bin Mohammed Alsagheir
Independent Director · since 2022
Fahad bin Suliman Bin Abdulrahman Alnuhait
Independent Director · since 2022
Nasser Hamd Mohammedbin Saif
Independent Director · since 2022
Valuation
Title SAR in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||